$0.00
(0.00%
) Quote details
USD
$0.00
(0.00%
)At Close (As of Nov 14, 2025)
$8.37B
Market Cap
15.02
P/E Ratio
4.74
EPS
$79.50
52 Week High
$42.01
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Halozyme Therapeutics, Inc. is an innovative biopharmaceutical company headquartered in San Diego, California, recognized for its groundbreaking drug delivery technologies that significantly enhance the effectiveness of existing therapies. Utilizing its proprietary ENHANZE® technology, Halozyme focuses on developing subcutaneous formulations that improve patient adherence and outcomes across a range of indications. The company strategically collaborates with industry-leading pharmaceutical partners, thereby expanding its therapeutic offerings and solidifying its role as a key player in the biotechnology sector. With a global operational footprint in the U.S., Europe, and Asia, Halozyme is well-positioned to meet the growing demand for more effective and patient-friendly therapeutic solutions.
LPTX
ASBP
TNMG
EPWK
VHAI
NVDA
BYND
PFE
TSLA
ASST
SOFI
PLUG
BITF
INTC
F
RGTI
SNAP
PLTR
TLRY
CIFR
WULF
NIO
ADAP
DNN
MARA
IREN
DVLT
QBTS
AMD
MKDW
APLD
APLT
CLSK
DFLI
CAN
GRAB
CSCO
SMCI
T
MU
KVUE
BABA
AAL
BAC
HOOD
WBD
NBIS
RIOT
RXRX
GOOGL
NOK
VZ
JD
PLTD
ORCL
HPE
QS
BTBT
RIG
IONQ
MSFT
SOUN
MTSR
HIMS
RKLB
SMR
LPTX
ASBP
TNMG
EPWK
VHAI
NVDA
BYND
PFE
TSLA
ASST
SOFI
PLUG
BITF
INTC
F
RGTI
SNAP
PLTR
TLRY
CIFR
WULF
NIO
ADAP
DNN
MARA
IREN
DVLT
QBTS
AMD
MKDW
APLD
APLT
CLSK
DFLI
CAN
GRAB
CSCO
SMCI
T
MU
KVUE
BABA
AAL
BAC
HOOD
WBD
NBIS
RIOT
RXRX
GOOGL
NOK
VZ
JD
PLTD
ORCL
HPE
QS
BTBT
RIG
IONQ
MSFT
SOUN
MTSR
HIMS
RKLB
SMR